Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peroxisomal biogenesis factor 12 (PEX12) is an **integral membrane protein** of the peroxisome, crucial for peroxisome biogenesis and maintenance[1][3]. PEX12 is one of three RING finger domain-containing proteins (the others are PEX2 and PEX10) that form a ubiquitin ligase complex embedded in the peroxisomal membrane[2][4][5]. This complex acts as a **retrotranslocation channel for recycling peroxisomal import receptors**, notably **PEX5**, which must be exported from the peroxisome back to the cytosol after delivering their cargo[3][4][5]. \n\nPEX12 specifically facilitates the **monoubiquitination of PEX5 via the E2 enzyme PEX4**, enabling receptor recycling. If PEX5 recycling fails, PEX12 supports PEX10-mediated polyubiquitination of PEX5, directing it toward proteasomal degradation[2][3][5]. Mutations in PEX12 are genetic causes of **peroxisomal biogenesis disorders** (PBDs), most notably **Zellweger syndrome** and related disorders, characterized by profound impairment of peroxisomal function[1][3]. \n\nPEX12 is a **359 amino acid, ~41 kDa protein** with two transmembrane segments and cytoplasmic N- and C-termini. The N-terminal region mediates correct localization to the peroxisome, while the C-terminal region contains an atypical RING finger domain essential for ubiquitin ligase activity and interactions with protein partners (including PEX5, PEX10, PEX19). It is conserved among all eukaryotes harboring peroxisomes[1][3][5]. \n\nThere are currently no drugs directly targeting PEX12, and it is not recognized as a traditional therapeutic target such as a receptor, enzyme, or transporter. Instead, its primary clinical role lies in genetics and diagnostics for peroxisome biogenesis disorders[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peroxisomal biogenesis factor 12 (PEX12).